VCC-001 has the potential to elicitate a humoral and cell-mediated immune response. Antigen presentation takes place by professional antigen presenting cells, and can trigger both, the development of cytotoxic T-lymphocytes and their proliferation and the development of antibodies.
Please join the video from Prof. Martin Marszalek explaining the Mode of Action of VCC-001
